Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines

No abstract is available for this paper.

• Publication year

  1989

• Venue

  International Journal of Cancer

• Publication date

  1989-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.2910440432PMID 2793247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells.

  1988cited by this paper
• Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.

  1988cited by this paper
• Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.

  1988cited by this paper
• Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme.

  1988cited by this paper
• Amplification of the epidermal growth factor receptor gene in the BT20 breast carcinoma cell line

  1987cited by this paper
• Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

  1987cited by this paper
• Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.

  1987cited by this paper
• Characterization of estrogen responsive transforming activity in human breast cancer cell lines.

  1986cited by this paper
• Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells.

  1986cited by this paper
• Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells.

  1986cited by this paper
• Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells.

  1986cited by this paper
• Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship.

  1986cited by this paper
• Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.

  1986cited by this paper
• Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters

  1985cited by this paper
• Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

  1985cited by this paper
• Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.

  1985cited by this paper
• MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.

  1985cited by this paper
• Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer.

  1985cited by this paper
• Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.

  1984cited by this paper
• Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.

  1984cited by this paper
• Regulation of high- and low-affinity epidermal growth factor receptors by glucocorticoids.

  1984cited by this paper
• Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.

  1983cited by this paper
• Receptor binding and processing of epidermal growth factor by human breast cancer cells.

  1982cited by this paper
• Processing of calcitonin and epidermal growth factor after binding to receptors in human breast cancer cells (T 47D).

  1982cited by this paper
• Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture.

  1982cited by this paper
• Interaction between glucocorticoids and epidermal growth factor in vitro in the growth of palatal mesenchymal cells from the human embryo.

  1981cited by this paper
• Distinctive effects of hydrocortisone on the modulation of EGF binding and cell growth in hela cells grown in defined medium

  1981cited by this paper
• The in vivo glucocorticoid and antiglucocorticoid actions of medroxyprogesterone acetate.

  1980cited by this paper
• Epidermal growth factor is a major growth-promoting agent in human milk.

  1980cited by this paper
• Autocrine secretion and malignant transformation of cells.

  1980cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Glucocorticoid-mediated alteration in growth factor binding and action: analysis of the binding change.

  1978cited by this paper
• Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture.

  1978cited by this paper
• Growth requirements of human mammary epithelial cells in culture

  1977cited by this paper
• Response to epidermal growth factors of cultured human mammary epithelial cells from benign tumours

  1976cited by this paper
• The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• Epidermal growth factor: identification of a new hormone in human urine.

  1975cited by this paper
• Control of growth of mammalian cells in cell culture

  1975cited by this paper
• Serum concentrations of epidermal growth factor in human pregnancy.

  1973cited by this paper
• Stimulation of mammary carcinoma cell proliferation by epithelial growth factor in vitro.

  1969cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• ChIP happens: from biochemical origins to the modern omics toolbox for understanding steroid hormone receptors

  2026cites this paper
• Functions of Dehydroepiandrosterone in Relation to Breast Cancer.

  2022cites this paper
• Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?

  2021cites this paper
• Stress hormone signalling contributes to tumourigenesis through the production of ROS/RNS, induction of DNA damage and interference with chemotherapy in breast cancer

  2017influential citation
• Epidermal growth factor receptor expression in gastric tumors and its relationship with the germline polymorphisms - 216 G>T, -191 C>A, (CA) n IVS1, and R521K.

  2016cites this paper
• Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: Comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex

  2015cites this paper
• Glucocorticoid Receptor (NR3C1) Promoter Methylation as a Circulating Breast Cancer Biomarker and its Role in Tamoxifen Sensitivity

  2014cites this paper
• Glucocorticoid receptor and breast cancer

  2011cites this paper
• Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1

  2011cites this paper
• Glucocorticoid receptor changes its cellular location with breast cancer development.

  2008cites this paper
• Breast Carcinoma: The glucocorticoid receptor signalling in breast cancer

  2008cites this paper
• Changes in oestrogen, progesterone and epidermal growth factor receptor concentrations and affinities during the oestrous cycle in the normal mammary gland and uterus of dogs

  2005cites this paper
• Expression of female sex hormone receptors in human middle-ear cholesteatomas

  2005cites this paper
• Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogendependent MXT mouse mammary cancers: Correlations between growth characteristics and EGF receptor content of tumors

  2005cites this paper
• Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing-hormone-releasing hormone in MXT mouse mammary carcinoma

  2005cites this paper
• Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas

  2004cites this paper
• Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells.

  2004cites this paper
• The Effect of Megestrol Acetate on Growth of HepG2 Cells In vitro and In vivo

  2004cites this paper
• The Glucocorticoid Receptor Represses the Positive Autoregulation of the Trout Estrogen Receptor Gene by Preventing the Enhancer Effect of a C/EBPβ-Like Protein.

  2002cites this paper
• Expression of progesterone receptor in human keratinocytes.

  2000cites this paper
• Transcriptional Interference Between Glucocorticoid Receptor and Estradiol Receptor Mediates the Inhibitory Effect of Cortisol on Fish Vitellogenesis1

  2000cites this paper
• Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells.

  2000cites this paper
• Progestin regulation of 11β-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells

  2000cites this paper
• Expression of the ErbB Family of Receptors in Ovarian Cancer

  1998cites this paper
• Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines.

  1998cites this paper
• Decrease in the level and mRNA expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice.

  1998cites this paper
• Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

  1997cites this paper
• Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.

  1997cites this paper
• A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.

  1997cites this paper
• 7 – Mammary stem cells in normal development and cancer

  1997cites this paper
• The antiglucocorticoid action of mifepristone.

  1996cites this paper
• Oestrogen receptor: a stable phenotype in breast cancer.

  1996cites this paper
• Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.

  1996cites this paper
• Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients.

  1996cites this paper
• Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester.

  1996cites this paper
• Relationship between receptors for epidermal growth factor and steroid hormones in normal, dysplastic and neoplastic canine mammary tissues.

  1996cites this paper
• The antiglucocorticoid action of mifepristone.

  1996cites this paper
• Regulation of epidermal growth factor receptor synthesis by ovarian steroids in human endometrial cells in culture.

  1996cites this paper
• Mechanisms of action of endocrine treatment in breast cancer.

  1995cites this paper
• The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids.

  1995cites this paper
• Prolactin and epidermal growth factor regulation of the proliferation, morphogenesis, and functional differentiation of normal rat mammary epithelial cells in three dimensional primary culture

  1995cites this paper
• Progestins and antiprogestins in mammary tumour growth and metastasis.

  1994cites this paper
• Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.

  1994cites this paper
• Epidermal growth factor and the maturation of intestinal sucrase in suckling rats.

  1993cites this paper
• Efficacy of pyridoxal treatment in controlling the growth of melanomas in cell culture and an animal pilot study.

  1993cites this paper
• Steroid regulation of oncofetal fibronectin expression in human cytotrophoblasts.

  1993cites this paper
• Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.

  1993cites this paper
• Effect of TGF‐Alpha on growth of normal human breast epithelial cells in serum‐free primary culture using 3‐dimensional collagen gels.

  1993cites this paper
• EGF receptor regulation in normal mouse mammary gland

  1992cites this paper
• Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095.

  1992cites this paper
• Progestins in breast cancer treatment. A review.

  1992cites this paper
• Progesterone receptors in breast cancer.

  1992cites this paper
• Oestrogen, progesterone, and glucocorticoid receptors in normal and neoplastic parathyroid glands.

  1992cites this paper
• Clinical Pharmacokinetics of Endocrine Agents Used in Advanced Breast Cancer

  1992cites this paper
• Molecular heterogeneity of somatostatin analogue BIM-23014C receptors in human breast carcinoma cells using the chemical cross-linking assay.

  1992cites this paper
• Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination

  1992cites this paper
• 4 – PROGESTINS AND OTHER PREGNANE DERIVATIVES

  1992cites this paper
• Modulation of tumor cell susceptibility to cytokine‐induced cell death by hormones, growth factors, and cell density

  1992cites this paper
• Low-dose aminoglutethimide therapy without glucocorticoid administration. Clinical and hormonal findings.

  1992cites this paper
• Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the breast cancer cell line T-47D.

  1991cites this paper
• Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes

  1991cites this paper
• Gonadal and adrenal effects on hepatic epidermal growth factor receptor expression in a murine model.

  1991cites this paper
• Glucocorticoid receptors in human malignancies: a review.

  1991cites this paper
• Steroid hormone receptor gene expression in human breast cancer cells: Inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels

  1990cites this paper
• Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells.

  1990cites this paper
• Inverse relationship between estrogen receptor and epidermal growth factor receptor mRNA levels in human breast cancer cell lines.

  1990cites this paper
• Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity.

  1990cites this paper
• Progestin regulation of cellular proliferation.

  1990cites this paper